Guardant Health Inc. (GH)
Guardant Health Statistics
Share Statistics
Guardant Health has 123.42M shares outstanding. The number of shares has increased by 1.51% in one year.
| Shares Outstanding | 123.42M |
| Shares Change (YoY) | 1.51% |
| Shares Change (QoQ) | 0.43% |
| Owned by Institutions (%) | 97.1% |
| Shares Floating | 117.96M |
| Failed to Deliver (FTD) Shares | 520 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 7.36M, so 5.96% of the outstanding shares have been sold short.
| Short Interest | 7.36M |
| Short % of Shares Out | 5.96% |
| Short % of Float | 6.26% |
| Short Ratio (days to cover) | 3.86 |
Valuation Ratios
The PE ratio is -8.59 and the forward PE ratio is -24.05. Guardant Health's PEG ratio is 0.51.
| PE Ratio | -8.59 |
| Forward PE | -24.05 |
| PS Ratio | 5.07 |
| Forward PS | 3.5 |
| PB Ratio | -26.85 |
| P/FCF Ratio | -13.64 |
| PEG Ratio | 0.51 |
Enterprise Valuation
Guardant Health Inc. has an Enterprise Value (EV) of 3.25B.
| EV / Earnings | -7.45 |
| EV / Sales | 4.4 |
| EV / EBITDA | -8.33 |
| EV / EBIT | -7.33 |
| EV / FCF | -11.82 |
Financial Position
The company has a current ratio of 4.68, with a Debt / Equity ratio of -9.57.
| Current Ratio | 4.68 |
| Quick Ratio | 4.36 |
| Debt / Equity | -9.57 |
| Total Debt / Capitalization | 111.67 |
| Cash Flow / Debt | -0.18 |
| Interest Coverage | -171.87 |
Financial Efficiency
Return on equity (ROE) is 3.12% and return on capital (ROIC) is -37.19%.
| Return on Equity (ROE) | 3.12% |
| Return on Assets (ROA) | -0.29% |
| Return on Capital (ROIC) | -37.19% |
| Revenue Per Employee | $369,692.85 |
| Profits Per Employee | $-218,295.65 |
| Employee Count | 1,999 |
| Asset Turnover | 0.5 |
| Inventory Turnover | 4.08 |
Taxes
| Income Tax | 1.28M |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 118.95% in the last 52 weeks. The beta is 1.5, so Guardant Health's price volatility has been higher than the market average.
| Beta | 1.5 |
| 52-Week Price Change | 118.95% |
| 50-Day Moving Average | 44.33 |
| 200-Day Moving Average | 32.67 |
| Relative Strength Index (RSI) | 53.55 |
| Average Volume (20 Days) | 2.4M |
Income Statement
In the last 12 months, Guardant Health had revenue of 739.02M and earned -436.37M in profits. Earnings per share was -3.56.
| Revenue | 739.02M |
| Gross Profit | 449.22M |
| Operating Income | -443.59M |
| Net Income | -436.37M |
| EBITDA | -390.12M |
| EBIT | -443.59M |
| Earnings Per Share (EPS) | -3.56 |
Balance Sheet
The company has 525.54M in cash and 1.34B in debt, giving a net cash position of -810.51M.
| Cash & Cash Equivalents | 525.54M |
| Total Debt | 1.34B |
| Net Cash | -810.51M |
| Retained Earnings | -2.58B |
| Total Assets | 1.49B |
| Working Capital | 829.53M |
Cash Flow
In the last 12 months, operating cash flow was -239.86M and capital expenditures -35.09M, giving a free cash flow of -274.94M.
| Operating Cash Flow | -239.86M |
| Capital Expenditures | -35.09M |
| Free Cash Flow | -274.94M |
| FCF Per Share | -2.24 |
Margins
Gross margin is 60.79%, with operating and profit margins of -60.02% and -59.05%.
| Gross Margin | 60.79% |
| Operating Margin | -60.02% |
| Pretax Margin | -58.87% |
| Profit Margin | -59.05% |
| EBITDA Margin | -52.79% |
| EBIT Margin | -60.02% |
| FCF Margin | -37.2% |
Dividends & Yields
GH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.88% |
| FCF Yield | -4.93% |
Analyst Forecast
The average price target for GH is $52, which is 15.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $52 |
| Price Target Difference | 15.1% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
Scores
| Altman Z-Score | -0.12 |
| Piotroski F-Score | 2 |